期刊文献+

帕洛诺司琼用于预防术后恶心呕吐的研究进展 被引量:6

The advance in clinical application of palonosetron to prevent postoperative nausea and vomiting
原文传递
导出
摘要 背景5-羟色胺3(5-HT3)受体拮抗剂特别是第2代5-HT3受体拮抗剂帕洛诺司琼对术后恶心呕吐(postoperativenauseaandvomiting,PONV)具有较好的预防作用,其药理学机制及临床应用状况近年来有了较为深入的研究和临床应用。目的分析总结帕洛诺对各类手术PONV的预防效果及其作用机制。内容第2代5-H%受体拮抗剂帕洛诺司琼具有高度亲和性、长效性、副作用少等优点,通过阻断5-H%与外周或中枢神经元的5-HT3受体结合,阻断迷走神经传人呕吐中枢和第四脑室化学感受区触发带,抑制呕吐反射,临床应用其预防PONV的高效性不断得到认可。趋向深入探讨其药理机制、副作用、预防PONV的临床应用等方面,以供临床工作者更加合理地应用其预防PONV。 Background The 5-HT3 antagonist, especially the second-generation of 5-HT3 antagonist palonosetron shows better efficacy against postoperative nausea and vomiting (PONV), its pharmacological mechanism and clinical efficacy were further investigated. Objective This paper sums up litures on its pharmacological mechanism and clinical efficacy on PONV prophylaxis. Content The second-generation 5-HT3 antagonist palonosetron has properties of greater receptor affinity, prolonged duration of action and few adverse effects. It blocks serotonin binding at vagal afferents in the gut and in the regions of the CNS involved in emesis, including the chemoreceptor trigger zone and the nucleus tractus solitarii, inhibits and emesis reflex, the high efficacy of palonosetron is being recognized. Trend This review summarizes its pharmacological mechanism of action, adverse effects, and clinical application on prevention of PONV, offering clinical reference to clinician to prevent PONV more reasonably.
作者 徐睿 姜虹
出处 《国际麻醉学与复苏杂志》 CAS 2013年第5期441-443,460,共4页 International Journal of Anesthesiology and Resuscitation
关键词 帕洛诺司琼 术后恶心呕吐 Palonosetron Postoperative nausea and vomiting
  • 相关文献

参考文献15

  • 1Tatic M, Skoric S, Miskovic S, et al. Postoperative nausea and vomiting. Med Pregl, 2003, 56(9-10): 431-435. 被引量:1
  • 2Fujii Y. The utility of antiemetics in the prevention and treatment of postoperative nausea and vomiting in patients scheduled for laparoscopic cholecystectomy. Curr Pharm Des, 2005, 11 (24) : 3173-3183. 被引量:1
  • 3Rojas C, Grunherg S, Rosti G. Creating real benefit for patients at risk of nausea and vomiting: palonosetron-from bench to bedside. Clin Adv Hematol Oncol, 2007, 5( 12 Suppl 19): 1-20. 被引量:1
  • 4Rojas C, Thomas AG, Alt J, et al. Palonsetron triggers 5-HT(3) reeepetor internalization and causes prolonged inhibition of receptor function. Eur J Pfiarrnaeol, 2010, 626(2-3): 193-199. 被引量:1
  • 5Stohz R, Cyong JC, Shah A, et evaluation of palonosetron, a 5 antagonist, in U.S. and Japanese macol, 2004, 44(5): 520-531. al. Pharmacokinetic and safety -hydroxytryptamine -3 receptor healthy subjects. J Clin Phar. 被引量:1
  • 6Eisenberg P, Figueroa-Vadillo J, Zamora R, et al. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron. Cancer, 2003, 98( 11 ) : 2473-2482. 被引量:1
  • 7Sept-lveda-Vild6sola AC, Betanzos-Cabrera Y, Lastifi GG, et al. Palonosetron hydrochloride is an effective and safe option to prevent chemotherapy-induced nausea and vomiting in children. Arch Med Res, 2008, 39(6): 601-606. 被引量:1
  • 8刘学胜,曾因明,张健.手术后恶心呕吐的研究进展[J].国外医学(麻醉学与复苏分册),2005,26(5):286-288. 被引量:44
  • 9Rojas C, Stathis M, Thomas AG, et al. Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor. Anesth Analg, 2008, 107(2): 469-478. 被引量:1
  • 10Bhattacharjee DP, Dawn S, Nayak S, et al. A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol, 2010, 26(4): 480-483. 被引量:1

二级参考文献30

  • 1魏欣,姚尚龙,张小洺.托烷司琼不同给药方式对术后镇痛恶心、呕吐的预防作用[J].临床麻醉学杂志,2007,23(6):454-456. 被引量:25
  • 2VADIVELU N,MITRA S,NARAYAN D.Recent advances in postoperative pain management[J].Yale J Biol Med,2010,83(1):11-25. 被引量:1
  • 3IGNOFFO R J.Current research on PONV/PDNV:Practical implications for today′s pharmacist[J].Am J Health Syst Pharm,2009,66(1 Suppl 1):S19-S24. 被引量:1
  • 4SEGAWA Y,AOGI K,INOUE K,et al.A phase Ⅱ dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy,including anthracycline and cyclophosphamide-based chemotherapy[J].Ann Oncol,2009,20(11):1874-1880. 被引量:1
  • 5GUPTA P,KHANNA J,MITRAMUSTAFI A K,et al.Role of pre-operative dexamethasone as prophylaxis for postoperative nausea and vomiting in laparoscopic surgery[J].J Minim Access Surg,2006,2(1):12-15. 被引量:1
  • 6HIRAYAMA T,ISHII F,YAGO K,et al.Evaluation of the effective drugs for the prevention of nausea and vomiting induced by morphine used for postoperative pain:a quantitative systematic review[J].Yakugaku Zasshi,2001,121(2):179-185. 被引量:1
  • 7BARTLETT S E,DODD P R,SMITH M T.Pharmacology of morphine and morphine-3-glucuronide at opioid,excitatory amino acid,GABA and glycine binding sites[J].Pharmacol Toxicol,1994,75(2):73-81. 被引量:1
  • 8MUCHATUTA N A,PAECH M J.Management of postoperative nausea and vomiting:focus on palonosetron[J].Ther Clin Risk Manag,2009,5(1):21-34. 被引量:1
  • 9ROJAS C,STATHIS M,THOMAS A G,et al.Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor[J].Anesth Analg,2008,107(2):469-478. 被引量:1
  • 10ROJAS C,THOMAS A G,ALT J,et al.Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function[J].Eur J Pharmacol,2010,626(2/3):193-199. 被引量:1

共引文献48

同被引文献42

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部